Results 21 to 30 of about 38,510 (295)
Cellular Signalling, 2013 Firstly described in 1992, the receptor for advanced glycation end-products has attracted increasing attention due to its diverse ligand repertoire and involvement in several pathophysiological processes associated with inflammation such as in diabetes, cancer, autoimmune diseases and neurodegenerative diseases. This receptor in addition to its binding
Rojas, Armando +5 more
openaire +5 more sources
Do advanced glycation end products contribute to food allergy? [PDF]
, 2023 Sugars can bind non-enzymatically to proteins, nucleic acids or lipids and form compounds called Advanced Glycation End Products (AGEs). Although AGEs can form in vivo, factors in the Western diet such as high amounts of added sugars, processing methods ...
P. K. Smith +12 more
core +1 more source
Assessment of Advanced Glycation End Products and Receptors and the Risk of Dementia [PDF]
JAMA Network Open, 2021 Advanced glycation end products (AGEs) and their receptor (RAGE) are implicated in the pathophysiological processes of dementia and potentially underlie the association of diabetes with neurodegeneration. However, longitudinal studies examining this association are lacking.To determine whether markers of the AGE-RAGE system are associated with ...
Chen, Jinluan +7 more
openaire +2 more sources
Participation of the Receptor for Advanced Glycation End Products in Efferocytosis [PDF]
The Journal of Immunology, 2011 Abstract Clearance of apoptotic cells by macrophages and other phagocytic cells, called efferocytosis, is a central process in the resolution of inflammation. Although the receptor for advanced glycation end products (RAGE) has been shown to participate in a variety of acute and chronic inflammatory processes in the lungs and other ...
Arnaud, Friggeri +6 more
openaire +2 more sources
Advanced Glycation End Products and Receptor for Advanced Glycation End Products in AA Amyloidosis
The American Journal of Pathology, 2003 Advanced glycation end products (AGEs) may be involved in either amyloidogenesis or complications related to amyloid. We hypothesized that AGEs may influence the pathogenesis of AA amyloidosis, and investigated the spatial and temporal relationship between AGEs, carboxy methyl lysine (CML), the AGE receptor (RAGE), and AA amyloid in humans and mice ...
Christoph, Röcken +8 more
openaire +3 more sources
Association between advanced glycation end products and impaired fasting glucose : results from the SALIA study [PDF]
, 2015 Advanced glycation end products (AGEs) may contribute to the development of type 2 diabetes and related complications, whereas their role in the early deterioration of glycaemia is unknown.
Annette Peßler +31 more
core +1 more source
Frontiers in Endocrinology, 2022 Atherosclerosis (AS) is a chronic inflammatory disease and leading cause of cardiovascular diseases. The progression of AS is a multi-step process leading to high morbidity and mortality. Hyperglycemia, dyslipidemia, advanced glycation end products (AGEs)
Lin Mao +3 more
doaj +1 more source
The critical role of methylglyoxal and glyoxalase 1 in diabetic nephropathy [PDF]
, 2014 The discovery of increased formation of methylglyoxal (MG) by cell metabolism in high glucose concentration in vitro suggested possible relevance to diabetes and diabetes complications (1,2).
Rabbani, Naila, Thornalley, Paul J.
core +1 more source
, 2022 This record contains raw data related to the article "Modulation of soluble receptor for advanced glycation end products isoforms and advanced glycation end products in long-living individuals" Background: Circulating levels of soluble receptor for ...
Raucci Angela
core +1 more source
Advanced glycation end products regulate the receptor of AGEs epigenetically
Frontiers in Cell and Developmental Biology, 2023 Advanced glycation end-products (AGEs) can boost their receptor of AGE (RAGE) expression through the downstream signaling pathway to facilitate AGE–RAGE interaction. In this regulation process, the primary signaling pathways are NF-κB and STAT3. However, the inhibition of these transcription factors cannot completely block the upregulation of RAGE ...
Xiaoqing Wu +4 more
openaire +3 more sources